Idexx Laboratories Profit Margin

As of the most recent data (September 2026), IDXX shows a profit margin of 25.36%. That compares with 24.65% in the prior-year period — up 2.9% year over year. That is above the Healthcare sector average of 19.13%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IDXX's profit margin is now 25.36% (was 24.65%) — a 2.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Idexx Laboratories is outperforming or lagging.

The Healthcare sector average profit margin is about 19.13%. Idexx Laboratories is at 25.36%, which is higher that average. That is roughly 32.5% above the sector mean. Use the comparison chart on this page to see how IDXX stacks up against individual peers as well.

That compares with 24.65% in the prior-year period — up 2.9% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Idexx Laboratories with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Idexx Laboratories's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 25.36%) with ownership activity and broader fundamentals.